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Abstract 
 
Two different recombinant proteins representing region II of the Duffy Binding Protein of 
Plasmodium vivax, DBP and PvRII expressed in the bacculovirus and Eschericia coli vector 
systems, respectively, were compared by assaying the total immunoglobulin (IgM + IgG) 
responses of sera of patients with acute vivax malaria in an indirect ELISA. The patients were 
from two malaria endemic areas, Anuradhapura (n=64) and Kataragama (n=90), and a non-
endemic area, Colombo (n=90). 
 
The antibody prevalence was 50% and 44% from Anuradhapura, 39% and 28% Kataragama 
and 57% and 41% from Colombo, for PvRII and DBP, respectively. The antibody prevalence 
for PvRII was higher than that for DBP in each test area, that was significant only in 
Colombo (p=0.001). The percentages of patients that they responded to both proteins were 
34% (n=22), 19% (n=17) and 40% (n=36) from Anuradhapura, Kataragama and from 
Colombo, respectively. In comparison, a significantly lower (p=0.007) percentage of 
individuals from Kataragama responded to both proteins. Further 16% (n=10) from 
Anuradhapura, 19% (n=17) from Kataragama and 16% (n=14) from Colombo preferentially 
recognised PvRII, whereas, corresponding values for DBP were 9% (n=6), 10% (n=9) and 
1% (n=1), respectively, where this difference was significant only in Colombo (p=0.031). 
Among the previously non-exposed patients from Colombo, 24% responded preferentially to 
PvRII whereas it was only 3% for DBP (p=0.021). On the other hand, of the previously 
exposed patients from Colombo, 10% preferentially responded to PvRII whereas no 
preferential recognition of DBP was observed (p=0.063). 
 
Thus the results of this study show a higher natural antibody response to recombinant protein 
PvRII, which represents the functional conformation of region II of the Duffy Binding 
Protein. 
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